Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Sequence specificity of streptozotocin-induced mutations.
Shigella sonnei
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.
Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike.
Risk management in therapeutics: when the patient becomes the last line of defense.
See All 7 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk management in therapeutics: when the patient becomes the last line of defense.
Gurwitz JH, Andrade SE. Risk management in therapeutics: when the patient becomes the last line of defense. Pharmacoepidemiol Drug Saf. 2002 Dec; 11(8):637-9.
View in:
PubMed
subject areas
Humans
Risk Management
Therapeutics